Organic compounds -- part of the class 532-570 series – Organic compounds – Four or more ring nitrogens in the bicyclo ring system
Reexamination Certificate
2006-11-28
2006-11-28
Owens, Amelia A. (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Four or more ring nitrogens in the bicyclo ring system
C544S262000, C514S262100
Reexamination Certificate
active
07141669
ABSTRACT:
Compounds of Formula (I) that act as cannabinoid receptor ligands and their uses in the treatment of diseases linked to the mediation of the cannabinoid receptors in animals are described herein
REFERENCES:
patent: 4925846 (1990-05-01), Deacon et al.
patent: 4944790 (1990-07-01), Moser et al.
patent: 5134142 (1992-07-01), Matsuo et al.
patent: 5462960 (1995-10-01), Barth et al.
patent: 5596106 (1997-01-01), Cullinan et al.
patent: 5624941 (1997-04-01), Barth et al.
patent: 5744491 (1998-04-01), Boigegrain et al.
patent: 5744493 (1998-04-01), Boigegrain et al.
patent: 5747524 (1998-05-01), Cullinan et al.
patent: 5925768 (1999-07-01), Barth et al.
patent: 6028084 (2000-02-01), Barth et al.
patent: 6100259 (2000-08-01), Xiang et al.
patent: 6344474 (2002-02-01), Maruani et al.
patent: 6355631 (2002-03-01), Achard et al.
patent: 6432984 (2002-08-01), Barth et al.
patent: 6444816 (2002-09-01), Das et al.
patent: 6476060 (2002-11-01), Lange et al.
patent: 6479479 (2002-11-01), Achard et al.
patent: 6509367 (2003-01-01), Martin et al.
patent: 6518264 (2003-02-01), Achard et al.
patent: 6566356 (2003-05-01), Achard et al.
patent: 2001/0027193 (2001-10-01), Achard et al.
patent: 2001/0053788 (2001-12-01), Lange et al.
patent: 2002/0019383 (2002-02-01), Achard et al.
patent: 2002/0019421 (2002-02-01), Biberman et al.
patent: 2002/0035102 (2002-03-01), Achard et al.
patent: 2002/0091114 (2002-07-01), Plot-Grosjean et al.
patent: 2002/0119972 (2002-08-01), Leftheris et al.
patent: 2002/0128302 (2002-09-01), Maruani et al.
patent: 2002/0188007 (2002-12-01), Barth et al.
patent: 2003/0003145 (2003-01-01), Abramovici et al.
patent: 2003/0055033 (2003-03-01), Achard et al.
patent: 2003/0114495 (2003-06-01), Finke et al.
patent: 2003/0139386 (2003-07-01), Cote et al.
patent: 2003/0199536 (2003-10-01), Thomas et al.
patent: 2004/0072833 (2004-04-01), Hisao et al.
patent: 2004/0077650 (2004-04-01), Dow
patent: 2004/0092520 (2004-05-01), Griffith
patent: 2004/0122074 (2004-06-01), Dow et al.
patent: 2004/0157838 (2004-08-01), Griffith
patent: 2004/0157839 (2004-08-01), Griffith
patent: 2004/0214837 (2004-10-01), Griffith et al.
patent: 2004/0214855 (2004-10-01), Carpino et al.
patent: 2004/0214856 (2004-10-01), Carpino et al.
patent: 2387138 (2001-04-01), None
patent: 5051518 (1994-08-01), None
patent: 1354884 (2003-10-01), None
patent: WO 96/02248 (1996-02-01), None
patent: WO0014088 (2000-03-01), None
patent: WO 00/15609 (2000-05-01), None
patent: 6642258 (2001-04-01), None
patent: WO 01/029007 (2001-04-01), None
patent: WO 01/032629 (2001-05-01), None
patent: WO 01/032663 (2001-05-01), None
patent: 2003087933 (2001-08-01), None
patent: WO 01/85092 (2001-11-01), None
patent: WO 02053565 (2002-07-01), None
patent: WO02074312 (2002-09-01), None
patent: WO 02/076949 (2002-10-01), None
patent: WO 03/006007 (2003-01-01), None
patent: WO 03/007887 (2003-01-01), None
patent: WO 03/018060 (2003-03-01), None
patent: WO 03/020217 (2003-03-01), None
patent: WO 03/020314 (2003-03-01), None
patent: WO 03/026647 (2003-04-01), None
patent: WO 03/026648 (2003-04-01), None
patent: WO 03/027069 (2003-04-01), None
patent: WO 03/027076 (2003-04-01), None
patent: WO 03/027114 (2003-04-01), None
patent: WO 03/040107 (2003-05-01), None
patent: WO03037899 (2003-05-01), None
patent: WO 03/051850 (2003-06-01), None
patent: WO 03/051851 (2003-06-01), None
patent: WO 03/075660 (2003-09-01), None
patent: WO 03/077847 (2003-09-01), None
patent: WO 03/078413 (2003-09-01), None
patent: WO 03/082190 (2003-10-01), None
patent: WO 03/082191 (2003-10-01), None
patent: WO 03/082256 (2003-10-01), None
patent: WO 03/082833 (2003-10-01), None
patent: WO 03/084943 (2003-10-01), None
patent: WO 03/086288 (2003-10-01), None
patent: WO 03/087037 (2003-10-01), None
patent: WO3080609 (2003-10-01), None
patent: WO 03095455 (2003-11-01), None
patent: WO 04/012617 (2004-02-01), None
Black, SC, Cannabinoid receptor antagonists and obesity. PMID: 15134279 (2004).
Ugarkar, B., et al.,J. Heterocyclic Chem., “A Simple Oxidation of Formycin to Oxoformycin and Oxoformycin B. Synthesis of 6-Methyloxoformycin, a C-Nucleoside Analog of Doridosine”, vol. 21, pp. 1865-1870 (1984).
Almansa, C., et al.,J. Med. Chem., “Synthesis and SAR of a New Series of COX-2-Selecitive Inhibitors Pyrazolo[1,5α]pyrimidines”, vol. 44, pp. 350-361 (2001).
Sharma, S.C., et al.,Acta Ciencia Iindica, “Nitrogen Hetercyclic Analogues of Cannabinoids Part II. Synthesis of 5-H-pyrazolo ′2,3-olbenzoxazine systems and evaluation of their biological activities”, vol. 12, No. 3, pp. 113-116 (1986).
Cusamo, G., et al.,Heterocycles, “Synthesis of 2-H-pyrazolo ′3,4-clquinoline derivatives by one pot rearrangement of phenylhydroazones of 3-acylindoles.”, vol. 24, No. 11, pp. 3181-3186 (1986).
Tzavara, E.T., et al., “The CB1 Receptor Antagonist SR14176A selectively increases monoaminergic neurotransmission in the medical prefrontal cortex: Implications for Therapeutic Actions,”J Pharmacol, 138, 544-553 (2003).
Racz, I., et al., “A Critical Role for the Cannabinoid CB1 Receptors in Alcohol Dependence and Stress-Stimulated Ethanol Drinking,”J Neurosci, 23(6), 2453-2458 (2003).
Croci, T., et al., “Role of Cannabinoid CB1 Receptors and Tumor Necrosis Factor-α in the gut and systemic anti-inflammatory activity of SR 141716 (Rimonabant) in rodents,”Brit J Pharmacol, 140, 115-122 (2003).
DaSilva, G.E., et al., “Potentiation of Penile Erection and Yawning Responses to Apomorphine by Cannabinoid Receptor Antagonists in Rats,”Neurosci Let, 349, 49-52 (2003).
Wang, L., et al., “Endocannabinoid Signaling via Cannabinoid Receptor 1 is Involved in Ethanol Preference and its Age-Dependent Decline in Mice,”PNAS, 100(3), 1393-1398 (2003).
Ruiu, S., et al., “Synthesis and Characterization of NESS 0327: A Novel Putative Antagonist of the CB1 Cannabinoid Receptor,”J Pharmacol Exp Therap, 306, 363-370 (2003).
Howlett, A.C., et al., “International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors,”Pharmacol Rev, 54, 161-202 (2002).
Gomez, R., et al., “A Peripheral Mechanism for CB1 Cannabinoid Receptor-Dependent Modulation of Feeding,”J. Neurosci, 22(21), 9612-9617 (2002).
Wiley, J.L., et al., “Novel Pyrazole Cannabinoids: Insights into CB1 Receptor Recognition and Activation,”J Pharmacol Exp Therap, 296(3), 1013-1022 (2001).
Lellemand, F., et al., “Effects of CB1 Cannabinoid Receptor Blockade on Ethanol Preference After Chronic Ethanol Administration,”Alcohol Clin Exp Res, 25(9), 1317-1323 (2001).
Pertwee, R.G., “Cannabinoids and the Gastronintestinal Tract,”Gut, 48, 859-867 (2001).
Pertwee, R.G., “Cannabinoid Receptor Ligands: Clinical and Neuropharmacological Considerations, Relevant to Future Drug Discovery and Development,”Exp. Opin. Invest. Drugs, 9(7), 1573-1571 (2000).
Hungund, B.L and B.S. Basavarajappa, “Are Anadamide and Cannabinoid Receptors involved in Ethanol Tolerance? A Review of the Evidence,”Alcohol&Alcoholism. 35(2) 126-133, (2000).
Freedland, C.S., et al., “Effects of SR141716A, a Central Cannabinoid Receptor Antagonist, on Food-maintained Responding,”Pharmacol Biochem Behav, 67, 265-270 (2000).
Lan, R., et al., “Structure-Activity Relationships of Pyrazole Derivatives as Cannabinoid Receptor Antagonists”J. Med. Che.m, 42, 769-776 (1999).
Pertwee, R.G., “Pharmacology of Cannabinoid Receptor Ligands”Curr Med Chem, 6, 635-664 (1999).
Basavarajappa, B.S., et al., “Chronic Ethanol Administration Down-regulates Cannabinoid Receptors in Mouse Brain Synaptic Plasma Membrane,”Brain Res, 793, 212-218 (1998).
Thomas, B.F., et al., “Comparative Receptor Binding Analyses of Cannabinoid Agonists and Antagonists,”J Pharmacol Exp Therap, 285, 285-292 (1998).
Colombo, G., et al., “Appetite Suppression and Weight Loss after the Cannabinoid Antagon
Carpino Philip A.
Griffith David A.
Benson Gregg C.
Musser Arlene K.
Owens Amelia A.
Pfizer Inc.
LandOfFree
Cannabiniod receptor ligands and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cannabiniod receptor ligands and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cannabiniod receptor ligands and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3690150